iRhythm Brass Face Suit Over FDA's Heart Monitor Inquiry
By Katryna Perera · May 20, 2024, 6:22 PM EDT
Several current and former directors and executives of medical technology company iRhythm are named in a shareholder derivative suit alleging they failed to disclose an inquiry by the Food and Drug...
To view the full article, register now.